Abz-Val-Ala-Asp-Nva-Arg-Asp-Arg-Gln-EDDnp

N-(2-aminobenzoyl)-L-valyl-L-alanyl-L-alpha-aspartyl-L-norvalyl-L-arginyl-L-alpha-aspartyl-L-arginyl-N1-[2-[(2,4-dinitrophenyl)amino]ethyl]-L-glutamamide is a sophisticated synthetic carbohydrate-peptide conjugate designed for advanced research applications in biochemistry and molecular biology. This compound integrates a sequence of amino acids with functionalized aromatic and dinitrophenyl groups, providing a versatile scaffold for probing biochemical pathways and molecular interactions. The unique structure enables selective recognition and interaction with a variety of biological targets, making it an invaluable tool for scientists investigating complex cellular processes or molecular recognition events. Its chemical stability and tailored functionalities allow for precise experimental manipulation, facilitating high-fidelity results in both in vitro and in situ assays.

Enzyme activity assays: Researchers utilize N-(2-aminobenzoyl)-L-valyl-L-alanyl-L-alpha-aspartyl-L-norvalyl-L-arginyl-L-alpha-aspartyl-L-arginyl-N1-[2-[(2,4-dinitrophenyl)amino]ethyl]-L-glutamamide as a chromogenic or fluorogenic substrate to monitor protease or peptidase activity in various biological samples. The presence of the dinitrophenyl group enables sensitive detection through spectrophotometric or fluorometric methods, allowing for real-time assessment of enzymatic cleavage. This application is particularly valuable in profiling enzyme specificity, screening for inhibitors, or characterizing kinetic parameters, thereby advancing understanding of proteolytic pathways and regulatory mechanisms. The compound's modular peptide sequence can be tailored to match the substrate preferences of target enzymes, further enhancing its utility in biochemical assays.

Protein-protein interaction studies: The peptide moiety of this conjugate serves as a molecular probe for dissecting protein-protein interactions, especially those involving recognition of specific peptide sequences or post-translational modifications. By incorporating the aromatic and dinitrophenyl tags, researchers can employ affinity-based techniques such as pull-down assays, surface plasmon resonance, or fluorescence resonance energy transfer to elucidate binding affinities and interaction dynamics. These insights are crucial for mapping signaling networks, identifying potential therapeutic targets, and understanding the molecular basis of cellular communication. The compound's stability and solubility profile make it suitable for high-throughput screening platforms as well as detailed mechanistic studies.

Cell signaling pathway analysis: Scientists leverage the distinctive features of N-(2-aminobenzoyl)-L-valyl-L-alanyl-L-alpha-aspartyl-L-norvalyl-L-arginyl-L-alpha-aspartyl-L-arginyl-N1-[2-[(2,4-dinitrophenyl)amino]ethyl]-L-glutamamide to investigate signal transduction cascades in cellular models. By acting as a substrate or competitive inhibitor, it can modulate the activity of key enzymes or receptors involved in signaling pathways, thereby revealing critical nodes of regulation. The compound's detectability via chromogenic or fluorogenic readouts enables precise quantification of pathway activation or inhibition, supporting the development of novel modulators or pathway-specific probes. Its compatibility with cell-based assays ensures relevance to physiological conditions and enhances translational research potential.

Biomarker discovery: The unique structural features of this carbohydrate-peptide conjugate facilitate its use in biomarker identification and validation studies. Scientists can exploit its selective binding properties to capture and enrich target molecules from complex biological matrices, such as serum or tissue lysates. Coupled with mass spectrometry or immunodetection techniques, it aids in the discovery of disease-associated proteins or peptides, contributing to the development of diagnostic tools and personalized medicine approaches. The compound's customizable sequence allows for adaptation to diverse biomarker targets, expanding its applicability across various disease models and research contexts.

Drug discovery and development: In the realm of pharmaceutical research, N-(2-aminobenzoyl)-L-valyl-L-alanyl-L-alpha-aspartyl-L-norvalyl-L-arginyl-L-alpha-aspartyl-L-arginyl-N1-[2-[(2,4-dinitrophenyl)amino]ethyl]-L-glutamamide is employed as a template for structure-activity relationship studies and high-throughput screening of candidate compounds. Its well-defined structure and functional groups make it an ideal model for evaluating binding affinities, specificity, and off-target effects of investigational drugs. By serving as a reference substrate or ligand, it supports the rational design of novel therapeutics aimed at modulating enzyme activity or protein-protein interactions. The compound's versatility and robust performance in diverse assay formats underscore its value to the drug discovery pipeline, enabling the identification and optimization of promising lead compounds.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate